Corrigendum to “NCX1 and NCX3: Two new effectors of delayed preconditioning in brain ischemia” (Neurobiology of Disease (2012) 45(1) (616–623)(S0969996111003391)(10.1016/j.nbd.2011.10.007));NCX1 and NCX3: Two new effectors of delayed preconditioning in brain ischemia

Neurobiology of Disease

Volumn 45, Issue 1, 2012, Pages 616-623

  Pignataro, Giuseppe ^a   Boscia, Francesca ^b   Esposito, Elga ^a   Sirabella, Rossana ^b   Cuomo, Ornella ^a   Vinciguerra, Antonio ^a   Di Renzo, Gianfranco ^a   Annunziato, Lucio ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS SDN   (Italy)

Author keywords

AKT; NCX; Neuroprotection; Preconditioning; Sodium calcium exchanger

Indexed keywords

ISOPROTEIN; PROTEIN KINASE B; SMALL INTERFERING RNA; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CALCIUM EXCHANGE PROTEIN 1; SODIUM CALCIUM EXCHANGE PROTEIN 2; SODIUM CALCIUM EXCHANGE PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; MALE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARIETAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

EID: 81955167359     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2016.12.002     Document Type: Erratum

References (24)

1. 2+ exchanger: from molecular biology to therapeutic perspectives. Pharmacol. Rev. 2004, 56:633-654.
2. 2+ exchanger in excitotoxicity. Cell 2005, 120:275-285.
3. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986, 17:1304-1308.
4. Boscia F., Gala R., Pannaccione A., Secondo A., Scorziello A., Di Renzo G., Annunziato L. NCX1 expression and functional activity increase in microglia invading the infarct core. Stroke 2009, 40:3608-3617.
5. 2+ exchanger gene expression in the ischemic core, periinfarct area, and intact brain regions. J. Cereb. Blood Flow Metab. 2006, 26:502-517.
6. Dirnagl U., Simon R.P., Hallenbeck J.M. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 2003, 26:248-254.
7. Endo H., Nito C., Kamada H., Nishi T., Chan P.H. Activation of the Akt/GSK3beta signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 2006, 26:1479-1489.
8. 2+ exchanger, NCX1 and NCX3, constitute novel additional targets for the prosurvival action of Akt/protein kinase B pathway. Mol. Pharmacol. 2008, 73:727-737.
9. Gidday J.M. Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 2006, 7:437-448.
10. 2+ homeostasis and viability in cerebellar neurons. J. Neurosci. 2005, 25:10822-10830.
11. Jones N.M., Bergeron M. Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. J. Cereb. Blood Flow Metab. 2001, 21:1105-1114.
12. Kirino T. Ischemic tolerance. J. Cereb. Blood Flow Metab. 2002, 22:1283-1296.
13. Meller R., Cameron J.A., Torrey D.J., Clayton C.E., Ordonez A.N., Henshall D.C., Minami M., Schindler C.K., Saugstad J.A., Simon R.P. Rapid degradation of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured neurons. J. Biol. Chem. 2006, 281:7429-7436.
14. 2+ exchanger 3 (NCX3) gene leads to a worsening of ischemic brain damage. J. Neurosci. 2008, 28:1179-1184.
15. 2+ exchanger, NCX3. J. Biol. Chem. 1996, 271:24914-24921.
16. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1997, Academic Press, New York.
17. Perez-Pinzon M.A., Xu G.P., Dietrich W.D., Rosenthal M., Sick T.J. Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. J. Cereb. Blood Flow Metab. 1997, 17:175-182.
18. Pignataro G., Gala R., Cuomo O., Tortiglione A., Giaccio L., Castaldo P., Sirabella R., Matrone C., Canitano A., Amoroso S., Di Renzo G., Annunziato L. Two sodium/calcium exchanger gene products, NCX1 and NCX3, play a major role in the development of permanent focal cerebral ischemia. Stroke 2004, 35:2566-2570.
19. Pignataro G., Meller R., Inoue K., Ordonez A.N., Ashley M.D., Xiong Z., Gala R., Simon R.P. In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning. J. Cereb. Blood Flow Metab. 2008, 28:232-241.
20. 2+ exchanger in cerebral ischemia induced by middle cerebral artery occlusion in male rats. Neuropharmacology 2004, 46:439-448.
21. Secondo A., Staiano R.I., Scorziello A., Sirabella R., Boscia F., Adornetto A., Valsecchi V., Molinaro P., Canzoniero L.M., Di Renzo G., Annunziato L. BHK cells transfected with NCX3 are more resistant to hypoxia followed by reoxygenation than those transfected with NCX1 and NCX2: possible relationship with mitochondrial membrane potential. Cell Calcium 2007, 42:521-535.
22. Stenzel-Poore M.P., Stevens S.L., Xiong Z., Lessov N.S., Harrington C.A., Mori M., Meller R., Rosenzweig H.L., Tobar E., Shaw T.E., Chu X., Simon R.P. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 2003, 362:1028-1037.
23. Valsecchi V., Pignataro G., Del Prete A., Sirabella R., Matrone C., Boscia F., Scorziello A., Sisalli M.J., Esposito E., Zambrano N., Di Renzo G., Annunziato L. NCX1 is a novel target gene for hypoxia-inducible factor-1 in ischemic brain preconditioning. Stroke 2011, 42:754-763.
24. Zhao H., Sapolsky R.M., Steinberg G.K. Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol. Neurobiol. 2006, 34:249-270.